Cargando…

437. Gram-Negative Rod Skin and Soft-tissue infections following Breast Tissue Expander Surgery in Breast Cancer Patients

BACKGROUND: Breast cancer patients who undergo tissue expander surgery (TES) are at an increased risk of developing gram-negative rod (GNR) skin and soft-tissue infection (SSIs) and its complications including prolonged antibiotic therapy, antibiotics side effects, and implant removal. Current perio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hee Katzman, Ju, Aslam, Sadaf, Pate, Donna Mae M, Guidish, Nicole, Power, Shelby, Maravilla, Clarissa, Perkins, Janelle, Greene, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809795/
http://dx.doi.org/10.1093/ofid/ofz360.510
_version_ 1783462084595417088
author Hee Katzman, Ju
Aslam, Sadaf
Pate, Donna Mae M
Guidish, Nicole
Power, Shelby
Maravilla, Clarissa
Perkins, Janelle
Greene, John
author_facet Hee Katzman, Ju
Aslam, Sadaf
Pate, Donna Mae M
Guidish, Nicole
Power, Shelby
Maravilla, Clarissa
Perkins, Janelle
Greene, John
author_sort Hee Katzman, Ju
collection PubMed
description BACKGROUND: Breast cancer patients who undergo tissue expander surgery (TES) are at an increased risk of developing gram-negative rod (GNR) skin and soft-tissue infection (SSIs) and its complications including prolonged antibiotic therapy, antibiotics side effects, and implant removal. Current perioperative antimicrobials focus mostly on gram-positive organisms, but the presence of a foreign body increases the risk of GNR SSI. We describe here the most common GNR bacteria and their susceptibility patterns that cause SSI after TES among breast cancer patients. METHODS: We conducted a retrospective cohort study at Moffitt Cancer Center, Tampa, FL from January 2016, to January 2018, on all breast cancer patients who developed GNR SSIs following TES. We reviewed records after approval from the Institutional Review Board. The data collected included patient’s age, pathogens from wound culture, antibiotic susceptibilities, the perioperative and definitive antibiotics used. RESULTS: A total of 38 cases of GNR SSI with a mean age of 56 ± 11 years were identified. The 3 most common pathogens were Pseudomonas aeruginosa (45%), Serratia marcescens (16%), and Klebsiella pneumoniae (8%) (Figure 1). The susceptibility pattern was available for 33 cases. Pseudomonas and Klebsiella isolates were susceptible to all tested antibiotics (Table 1). The Stenotrophomonas isolates showed resistance to ceftazidime. Enterobacter cloacae, Enterobacter aerogenes, Morganella morganii, and Acinetobacter baumannii complex, showed resistance to cefazolin. Twenty-five cases (74%) received perioperative antibiotics for gram-positive organisms; mostly cefazolin, and vancomycin. The common antibiotics used for definitive treatment were ciprofloxacin, cefepime, ceftazidime, piperacillin–tazobactam, and meropenem. CONCLUSION: In centers with a high percentage of GNR SSI following TES should consider using perioperative antibiotics that include coverage against Pseudomonas aeruginosa, the most common isolate (45%). The use only of cefazolin or other antibiotics against gram-positive organism may be inadequate. However, GNR infection may occur from 48 hours to 2 weeks postoperatively and may be from the acquisition of the GNR at home in which perioperative antibiotics may have minimal effect. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6809795
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68097952019-10-28 437. Gram-Negative Rod Skin and Soft-tissue infections following Breast Tissue Expander Surgery in Breast Cancer Patients Hee Katzman, Ju Aslam, Sadaf Pate, Donna Mae M Guidish, Nicole Power, Shelby Maravilla, Clarissa Perkins, Janelle Greene, John Open Forum Infect Dis Abstracts BACKGROUND: Breast cancer patients who undergo tissue expander surgery (TES) are at an increased risk of developing gram-negative rod (GNR) skin and soft-tissue infection (SSIs) and its complications including prolonged antibiotic therapy, antibiotics side effects, and implant removal. Current perioperative antimicrobials focus mostly on gram-positive organisms, but the presence of a foreign body increases the risk of GNR SSI. We describe here the most common GNR bacteria and their susceptibility patterns that cause SSI after TES among breast cancer patients. METHODS: We conducted a retrospective cohort study at Moffitt Cancer Center, Tampa, FL from January 2016, to January 2018, on all breast cancer patients who developed GNR SSIs following TES. We reviewed records after approval from the Institutional Review Board. The data collected included patient’s age, pathogens from wound culture, antibiotic susceptibilities, the perioperative and definitive antibiotics used. RESULTS: A total of 38 cases of GNR SSI with a mean age of 56 ± 11 years were identified. The 3 most common pathogens were Pseudomonas aeruginosa (45%), Serratia marcescens (16%), and Klebsiella pneumoniae (8%) (Figure 1). The susceptibility pattern was available for 33 cases. Pseudomonas and Klebsiella isolates were susceptible to all tested antibiotics (Table 1). The Stenotrophomonas isolates showed resistance to ceftazidime. Enterobacter cloacae, Enterobacter aerogenes, Morganella morganii, and Acinetobacter baumannii complex, showed resistance to cefazolin. Twenty-five cases (74%) received perioperative antibiotics for gram-positive organisms; mostly cefazolin, and vancomycin. The common antibiotics used for definitive treatment were ciprofloxacin, cefepime, ceftazidime, piperacillin–tazobactam, and meropenem. CONCLUSION: In centers with a high percentage of GNR SSI following TES should consider using perioperative antibiotics that include coverage against Pseudomonas aeruginosa, the most common isolate (45%). The use only of cefazolin or other antibiotics against gram-positive organism may be inadequate. However, GNR infection may occur from 48 hours to 2 weeks postoperatively and may be from the acquisition of the GNR at home in which perioperative antibiotics may have minimal effect. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809795/ http://dx.doi.org/10.1093/ofid/ofz360.510 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Hee Katzman, Ju
Aslam, Sadaf
Pate, Donna Mae M
Guidish, Nicole
Power, Shelby
Maravilla, Clarissa
Perkins, Janelle
Greene, John
437. Gram-Negative Rod Skin and Soft-tissue infections following Breast Tissue Expander Surgery in Breast Cancer Patients
title 437. Gram-Negative Rod Skin and Soft-tissue infections following Breast Tissue Expander Surgery in Breast Cancer Patients
title_full 437. Gram-Negative Rod Skin and Soft-tissue infections following Breast Tissue Expander Surgery in Breast Cancer Patients
title_fullStr 437. Gram-Negative Rod Skin and Soft-tissue infections following Breast Tissue Expander Surgery in Breast Cancer Patients
title_full_unstemmed 437. Gram-Negative Rod Skin and Soft-tissue infections following Breast Tissue Expander Surgery in Breast Cancer Patients
title_short 437. Gram-Negative Rod Skin and Soft-tissue infections following Breast Tissue Expander Surgery in Breast Cancer Patients
title_sort 437. gram-negative rod skin and soft-tissue infections following breast tissue expander surgery in breast cancer patients
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809795/
http://dx.doi.org/10.1093/ofid/ofz360.510
work_keys_str_mv AT heekatzmanju 437gramnegativerodskinandsofttissueinfectionsfollowingbreasttissueexpandersurgeryinbreastcancerpatients
AT aslamsadaf 437gramnegativerodskinandsofttissueinfectionsfollowingbreasttissueexpandersurgeryinbreastcancerpatients
AT patedonnamaem 437gramnegativerodskinandsofttissueinfectionsfollowingbreasttissueexpandersurgeryinbreastcancerpatients
AT guidishnicole 437gramnegativerodskinandsofttissueinfectionsfollowingbreasttissueexpandersurgeryinbreastcancerpatients
AT powershelby 437gramnegativerodskinandsofttissueinfectionsfollowingbreasttissueexpandersurgeryinbreastcancerpatients
AT maravillaclarissa 437gramnegativerodskinandsofttissueinfectionsfollowingbreasttissueexpandersurgeryinbreastcancerpatients
AT perkinsjanelle 437gramnegativerodskinandsofttissueinfectionsfollowingbreasttissueexpandersurgeryinbreastcancerpatients
AT greenejohn 437gramnegativerodskinandsofttissueinfectionsfollowingbreasttissueexpandersurgeryinbreastcancerpatients